Fate Therapeutics, Inc. (FATE)
1.85
-0.24
(-11.48%)
USD |
NASDAQ |
Nov 05, 16:00
1.81
-0.04
(-2.16%)
After-Hours: 20:00
Fate Therapeutics Net Income (TTM) : -126.00M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -126.00M |
| March 31, 2026 | -129.91M |
| December 31, 2025 | -136.32M |
| September 30, 2025 | -156.09M |
| June 30, 2025 | -171.52M |
| March 31, 2025 | -175.88M |
| December 31, 2024 | -186.26M |
| September 30, 2024 | -178.23M |
| June 30, 2024 | -175.72M |
| March 31, 2024 | -190.05M |
| December 31, 2023 | -160.93M |
| September 30, 2023 | -173.17M |
| June 30, 2023 | -211.56M |
| March 31, 2023 | -234.91M |
| December 31, 2022 | -281.72M |
| September 30, 2022 | -293.98M |
| June 30, 2022 | -253.72M |
| March 31, 2022 | -232.75M |
| December 31, 2021 | -212.15M |
| September 30, 2021 | -196.64M |
| June 30, 2021 | -212.02M |
| March 31, 2021 | -184.96M |
| December 31, 2020 | -173.39M |
| September 30, 2020 | -148.58M |
| June 30, 2020 | -116.50M |
| Date | Value |
|---|---|
| March 31, 2020 | -111.91M |
| December 31, 2019 | -98.15M |
| September 30, 2019 | -85.87M |
| June 30, 2019 | -76.05M |
| March 31, 2019 | -72.22M |
| December 31, 2018 | -66.60M |
| September 30, 2018 | -63.07M |
| June 30, 2018 | -56.97M |
| March 31, 2018 | -46.96M |
| December 31, 2017 | -42.95M |
| September 30, 2017 | -38.40M |
| June 30, 2017 | -36.45M |
| March 31, 2017 | -35.21M |
| December 31, 2016 | -33.46M |
| September 30, 2016 | -32.97M |
| June 30, 2016 | -31.12M |
| March 31, 2016 | -30.49M |
| December 31, 2015 | -29.99M |
| September 30, 2015 | -28.78M |
| June 30, 2015 | -28.50M |
| March 31, 2015 | -26.78M |
| December 31, 2014 | -25.88M |
| September 30, 2014 | -25.39M |
| June 30, 2014 | -24.86M |
| March 31, 2014 | -24.33M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AVITA Medical, Inc. | -43.08M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 9.391B |
| Anika Therapeutics, Inc. | -3.121M |
| BioCryst Pharmaceuticals, Inc. | -359.66M |